Xuanzhu Biopharmaceutical Co., Ltd.

This study looks at how the antibiotic rifampin changes the way the body processes anaprazole, a stomach acid reducer. It involves 24 healthy adults aged 18-45. The goal is to measure drug levels and check for side effects when both drugs are taken together.

This study looks at how the body handles anaprazole sodium in adults with liver or kidney impairment and in elderly people. Researchers will measure drug levels in the blood and track any side effects. The goal is to understand if the drug behaves differently in these groups comp…